Medifast (NYSE:MED) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.27) by 74.07 percent. This is a 110.61 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $115.73 million which beat the analyst consensus estimate of $110.10 million by 5.11 percent. This is a 33.77 percent decrease over sales of $174.74 million the same period last year.